PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...
Medtronic (NYSE: MDT) today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.
Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...
New data from the United States bolster the case for dementia prevention. At the same time, noninvasive stimulation procedures are still not being used to treat Alzheimer's disease (AD) in day-to-day ...
2d
A Fresh Look at Medtronic (MDT) Valuation After FDA Green Light for Altaviva Neuromodulation Device
Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment ...
Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...
As some cardiovascular and neuromodulation procedures migrate from hospitals to outpatient settings in certain states, continued growth in the Ambulatory Surgery Center (ASC) and Office-Based Lab (OBL ...
The registration certificate (????20252090343), issued on August 11, 2025, marks the first and only approval in China of a ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Turing Medical, the leader in precision targeting for neuromodulation therapies, today announced the launch of Bullsai, its new brain mapping and targeting solution, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback